ENEA Tech Video

BetaGlue Therapeutics and its shareholders are proud to collaborate with Fondazione Policlinico Universitario Agostino Gemelli in the fight against cancer. Our clinical study in locally advanced pancreatic cancer is on-going. Learn more with this video.

Coming soon

Events

See what BetaGlue will attend
MioLive - Roma

World Congress of Interventional Oncology

MIOLive

January 26-27, 2026 | Università Cattolica del Sacro Cuore

Rome, Italy

Register interest: info@betaglue.com


Gianluca
De Danieli
Head of Clinical Development
Spectrum Miami

Advancements in the fight against cancer

Spectrum Conference

January 15-17, 2026 | JW Marriott Miami

Miami (FL), USA

Register interest: info@betaglue.com


Alexis
Peyroles
CEO
Salvatore
Calabrese
CFO
Gianluca
De Danieli
Head of Clinical Development
San Francisco - JP Morgan Health Conference

44th Annual J.P. Morgan

Healthcare Conference

January 12-15, 2026 | Westin St. Francis

San Francisco (CA), USA

Register interest: info@betaglue.com


Alexis
Peyroles
CEO
Salvatore
Calabrese
CFO
Gianluca
De Danieli
Head of Clinical Development

What we’re building

News

Discover the latest from our lab and clinic
BetaGlue® has enrolled the first patient treated with BAT-90 in its First-in-Human trials, taking radiotherapy inside solid tumors
Beta glue trials

BetaGlue® has enrolled the first patient treated with BAT-90 in its First-in-Human trials, taking radiotherapy inside solid tumors

The first clinical findings have shown that BAT-90 makes it possible to treat onlythe area where the tumor is located, while avoiding the surrounding tissues, so as to combine treatmentefficacy…

Read more
1000 563 BetaGlue Therapeutics
BetaGlue® Technologies announces new Board of Directors

BetaGlue® Technologies announces new Board of Directors

BetaGlue (www.betaglue.com), an innovative Italian company in the field of interventional oncology today announced the appointment of its new Board of Directors, composed by investors representatives, independent industry experts and…

Read more
1200 798 BetaGlue Therapeutics